New cream aims to soothe rash caused by cancer drugs
NCT ID NCT04731259
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a cream called ATR-04 to see if it could safely reduce the facial rash caused by certain cancer drugs (EGFR inhibitors). About 60 adults with cancer who were about to start these drugs were planned to join. The study was withdrawn before any participants enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- Can a skin ointment calm two stubborn redness conditions?
- A simple screening program could transform cancer aftercare